We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNKD
851
DELISTED
LinkedIn Corporation
LNKD
| $450K | ﹤0.01% |
+1,800
| New | +$447K |
|
|
AMTD
852
DELISTED
TD Ameritrade Holding Corp
AMTD
| $436K | ﹤0.01% |
11,711
-196,890
| -94% | -$7M |
|
|
DFT
853
DELISTED
DuPont Fabros Technology Inc.
DFT
| $435K | ﹤0.01% |
+13,300
| New | +$449K |
|
854
MarineMax
HZO
$1.15B
| $431K | ﹤0.01% |
+16,249
| New | +$397K |
|
855
Renasant Corp
RNST
$3.88B
| $429K | ﹤0.01% |
14,260
-2,583
| -15% | -$72.8K |
|
856
Edgewell Personal Care
EPC
$1.28B
| $428K | ﹤0.01% |
4,179
-26,759
| -86% | -$2.65M |
|
857
Medifast
MED
$135M
| $426K | ﹤0.01% |
+14,200
| New | +$451K |
|
858
SLB Ltd
SLB
$77.7B
| $426K | ﹤0.01% |
+5,100
| New | +$425K |
|
859
Liberty Media Series A
FWONA
$23.5B
| $425K | ﹤0.01% |
16,390
-215,028
| -93% | -$5.37M |
|
860
Jabil
JBL
$35.8B
| $423K | ﹤0.01% |
+18,100
| New | +$395K |
|
861
OneSpan
OSPN
$617M
| $420K | ﹤0.01% |
+19,500
| New | +$462K |
|
|
CDR
862
DELISTED
Cedar Realty Trust, Inc
CDR
| $418K | ﹤0.01% |
8,455
-34,745
| -80% | -$1.75M |
|
863
Helix Energy Solutions
HLX
$1.46B
| $414K | ﹤0.01% |
+27,700
| New | +$468K |
|
864
First Merchants
FRME
$2.65B
| $411K | ﹤0.01% |
17,447
| – | – |
|
865
MillerKnoll
MLKN
$1.63B
| $411K | ﹤0.01% |
+14,800
| New | +$433K |
|
866
PPG Industries
PPG
$25.9B
| $411K | ﹤0.01% |
3,642
-2,602
| -42% | -$298K |
|
867
Trimble
TRMB
$13.8B
| $408K | ﹤0.01% |
+16,190
| New | +$415K |
|
868
Nordson
NDSN
$17.2B
| $407K | ﹤0.01% |
+5,200
| New | +$394K |
|
869
Agilent Technologies
A
$41.8B
| $403K | ﹤0.01% |
9,700
-7,745
| -44% | -$313K |
|
870
Enphase Energy
ENPH
$5.45B
| $395K | ﹤0.01% |
+29,930
| New | +$387K |
|
|
DFRG
871
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $390K | ﹤0.01% |
+19,379
| New | +$390K |
|
872
Alcoa
AA
$13.6B
| $389K | ﹤0.01% |
12,526
-38,616
| -76% | -$1.39M |
|
|
DISCK
873
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $389K | ﹤0.01% |
+13,206
| New | +$399K |
|
|
BDSI
874
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $387K | ﹤0.01% |
+36,860
| New | +$504K |
|
875
Cummins
CMI
$88.2B
| $386K | ﹤0.01% |
2,784
-532,443
| -99% | -$75M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.